Medallia (NASDAQ:MDLA) Director Borge Hald sold 1,765,000 shares of the company’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $19.53, for a total transaction of $34,470,450.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
NASDAQ MDLA opened at $41.50 on Friday. Medallia has a 1-year low of $32.05 and a 1-year high of $44.72.
Separately, Stifel Nicolaus downgraded shares of Viveve Medical from a “buy” rating to a “hold” rating and dropped their price target for the stock from $3.00 to $1.00 in a research note on Monday.
Medallia, Inc provides an enterprise Software-as-a-Service platform in North America, Europe, the Middle East, Africa, and internationally. The company's platform utilizes deep learning-based artificial intelligence technology to analyze structured and unstructured data from signal fields in human, digital, and Internet of Things interactions.
Featured Story: Cash Flow
Receive News & Ratings for Medallia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medallia and related companies with MarketBeat.com's FREE daily email newsletter.